Interestingly, increased expression of MLC1 at the perivascular astrocyte end-feet has been observed in the brain of patients affected by AD, MS, and also prion disease [31], which might indicate an attempt to ameliorate these pathological processes by increased MLC1 expression in activated astrocytes. This evidence concerns the gene MLC1 and myeloid sarcoma.